Innovative Multidisciplinary Strategies for Combating Severe Dengue

Recruiting Observational Study
DENV Without Warning Signs DENV with Warning Signs Severe Dengue Healthy Controls Group - Age and Sex-matched
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
1,400 (estimated)
Sponsor
Karolinska Institutet · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The goal of this observational study is to identify biomarkers and host factors associated with dengue severity in patients from dengue-endemic regions. The main question it aims to answer is: Can multi-omics approaches predict disease severity and identify key factors contributing to severe dengue infections? Participants will include individuals with dengue infection, and the study will analyz…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: Group 1: Dengue without warning signs Patients presenting with the following symptoms confirmed positive for dengue infection by lab diagnosis by anti-dengue IgM or NS1 ELISA will be recruited for the study under this cohort. Symptoms will be fever along with at least two of th…
Contacts

Ujjwal Neogi, PhD

+46 8524 83680

ujjwal.neogi@ki.se

CONTACT